| 37 |
ZYDENA Poised to Enter Global Market with Phase III Clinical Trial Starting for US FDA Approval |
2009-11-11 |
| 36 |
Dong-A Pharmaceutical Acquires a License for a New Arthritis Drug Made of Natural Substance |
2009-07-31 |
| 35 |
“Bright Vision of Dong-A with DA-7218” |
2009-06-19 |
| 34 |
Erectile Dysfunction Treatment ZYDENA Hits the Russian Market |
2009-05-06 |
| 33 |
Dong-A Signs License Agreement to Exclusively Develop and Market Asahi Kasei’s FLIVAS, a Prostatism Treatment, in Korea |
2009-05-06 |
| 32 |
Dong-A Takes on Global Markets in R&D Collaboration with Japan’s Otsuka |
2009-04-13 |
| 31 |
Dong-A Plans Aggressive R&D in 2009 to Overcome Economic Slump |
2009-03-18 |
| 30 |
Development of Gene Therapy for Brain Tumor |
2009-03-04 |
| 29 |
Erectile Dysfunction Drug ZYDENA Captures No. 2 Position |
2009-03-04 |
| 28 |
Dong-A’s super bacteria-targeting antibiotic enters phase 2 in the U.S. |
2009-01-29 |
